View Item 

Show simple item record

V1b Receptor Antagonist SSR149415 and Naltrexone Synergistically Decrease Excessive Alcohol Drinking in Male and Female Mice

dc.contributor.authorZhou, Yan
dc.contributor.authorRubinstein, Marcelo
dc.contributor.authorLow, Malcolm J.
dc.contributor.authorKreek, Mary Jeanne
dc.date.accessioned2018-02-05T16:33:18Z
dc.date.available2019-03-01T21:00:17Zen
dc.date.issued2018-01
dc.identifier.citationZhou, Yan; Rubinstein, Marcelo; Low, Malcolm J.; Kreek, Mary Jeanne (2018). "V1b Receptor Antagonist SSR149415 and Naltrexone Synergistically Decrease Excessive Alcohol Drinking in Male and Female Mice." Alcoholism: Clinical and Experimental Research 42(1): 195-205.
dc.identifier.issn0145-6008
dc.identifier.issn1530-0277
dc.identifier.urihttps://hdl.handle.net/2027.42/141424
dc.publisherWiley Periodicals, Inc.
dc.subject.otherCombined Therapy
dc.subject.othernPE Knockout Mice
dc.subject.otherSSR149415
dc.subject.otherV1b Receptor
dc.subject.otherExcessive Alcohol Drinking
dc.subject.otherNaltrexone
dc.titleV1b Receptor Antagonist SSR149415 and Naltrexone Synergistically Decrease Excessive Alcohol Drinking in Male and Female Mice
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141424/1/acer13544.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141424/2/acer13544_am.pdf
dc.identifier.doi10.1111/acer.13544
dc.identifier.sourceAlcoholism: Clinical and Experimental Research
dc.identifier.citedreferenceSimms JA, Nielsen CK, Li R, Bartlett SE ( 2014 ) Intermittent access ethanol consumption dysregulates CRF function in the hypothalamus and is attenuated by the CRF‐R1 antagonist, CP‐376395. Addict Biol 19: 606 – 611.
dc.identifier.citedreferenceKoob GF ( 2008 ) A role for brain stress systems in addiction. Neuron 59: 11 – 34.
dc.identifier.citedreferenceKoob GF, Kreek MJ ( 2007 ) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164: 1149 – 1159.
dc.identifier.citedreferenceLam DD, de Souza FS, Nasif S, Yamashita M, López‐Leal R, Otero‐Corchon V, Meece K, Sampath H, Mercer AJ, Wardlaw SL, Rubinstein M, Low MJ ( 2015 ) Partially redundant enhancers cooperatively maintain Mammalian pomc expression above a critical functional threshold. PLoS Genet 11: e1004935.
dc.identifier.citedreferenceO’Malley S, Krishnan‐Sarin S, Farren C, Sinha R, Kreek MJ ( 2002 ) Naltrexone decreases craving and alcohol self‐administration in alcohol‐dependent subjects and activates the hypothalamic‐pituitary‐adrenocortical axis. Psychopharmacology 160: 19 – 29.
dc.identifier.citedreferenceOost T, Backfisch G, Bhowmik S, van Gaalen MM, Geneste H, Hornberger W, Lubisch W, Netz A, Unger L, Wernet W ( 2011 ) Potent and selective oxindole‐based vasopressin 1b receptor antagonists with improved pharmacokinetic properties. Bioorg Med Chem Lett 21: 3828 – 3831.
dc.identifier.citedreferenceQi X, Guzhva L, Ji Y, Bruijnzeel AW ( 2015 ) Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats. Behav Brain Res 292: 259 – 265.
dc.identifier.citedreferenceRhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC ( 2005 ) Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav 84: 53 – 63.
dc.identifier.citedreferenceRoper JA, O’Carroll A, Young WS III, Lolait SJ ( 2011 ) The vasopressin AVPr1b receptor: molecular and pharmacological studies. Stress 14: 98 – 115.
dc.identifier.citedreferenceRyan ML, Falk DE, Fertig JB, Rendenbach‐Mueller B, Katz DA, Tracy KA, Strain EC, Dunn KE, Kampman K, Mahoney E, Ciraulo DA, Sickles‐Colaneri L, Ait‐Daoud N, Johnson BA, Ransom J, Scott C, Koob GF, Litten RZ ( 2017 ) A phase 2, double‐blind, placebo‐controlled randomized trial assessing the efficacy of ABT‐436, a novel V1b receptor antagonist, for alcohol dependence. Neuropsychopharmacology 42: 1012 – 1023.
dc.identifier.citedreferenceSalome N, Stemmelin J, Cohen C, Griebel G ( 2006 ) Differential roles of amygdaloid nuclei in the anxiolytic‐ and antidepressant‐like effects of the V1b receptor antagonist, SSR149415, in rats. Psychopharmacology 187: 237 – 244.
dc.identifier.citedreferenceSilva SM, Madeira MD, Ruela C, Paula‐Barbosa MM ( 2002 ) Prolonged alcohol intake leads to irreversible loss of vasopressin and oxytocin neurons in the paraventricular nucleus of the hypothalamus. Brain Res 925: 76 – 88.
dc.identifier.citedreferenceSprow GM, Rinker JA, Lowery‐Gointa EG, Sparrow AM, Navarro M, Thiele TE ( 2016 ) Lateral hypothalamic melanocortin receptor signaling modulates binge‐like ethanol drinking in C57BL/6J mice. Addict Biol 21: 835 – 846.
dc.identifier.citedreferenceStewart LQ, Roper JA, Young WS 3rd, O’Carroll AM, Lolait SJ ( 2008 ) The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants. Psychoneuroendocrinology 33: 405 – 415.
dc.identifier.citedreferenceTrabert W, Caspari D, Bernhard P, Biro G ( 1992 ) Inappropriate vasopressin secretion in severe alcohol withdrawal. Acta Psychiatr Scand 85: 376 – 379.
dc.identifier.citedreferenceTunstall BJ, Carmack SA, Koob GF, Vendruscolo LF ( 2017 ) Dysregulation of brain stress systems mediates compulsive alcohol drinking. Curr Opin Behav Sci 13: 85 – 90.
dc.identifier.citedreferenceVeinante P, Freund‐Mercier MJ ( 1997 ) Distribution of oxytocin‐ and vasopressin‐binding sites in the rat extended amygdala: a histoautoradiographic study. J Comp Neurol 383: 305 – 325.
dc.identifier.citedreferenceZhou Y, Colombo G, Carai MA, Ho A, Gessa GL, Kreek MJ ( 2011 ) Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol‐preferring rats. Alcohol Clin Exp Res 35: 1876 – 1883.
dc.identifier.citedreferenceZhou Y, Crowley RS, Ben K, Prisinzano TE, Kreek MJ ( 2017a ) Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone. Brain Res 1662: 75 – 86.
dc.identifier.citedreferenceZhou Y, Leri F, Cumming E, Hoeschele M, Kreek MJ ( 2008 ) Involvement of arginine vasopressin and its V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin. Neuropsychopharmacology 33: 226 – 236.
dc.identifier.citedreferenceZhou Y, Rubinstein M, Low MJ, Kreek MJ ( 2017b ) Hypothalamic‐specific proopiomelanocortin deficiency reduces alcohol drinking in male and female mice. Genes Brain Behav 16: 449 – 461.
dc.identifier.citedreferenceZhou Y, Schwartz BI, Giza J, Gross SS, Lee FS, Kreek MJ ( 2017c ) Blockade of alcohol escalation and “relapse” drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice. Psychopharmacology 234: 2955 – 2970.
dc.identifier.citedreferenceBecker JB, Koob GF ( 2016 ) Sex differences in animal models: focus on addiction. Pharmacol Rev 68: 242 – 263.
dc.identifier.citedreferenceBumaschny VF, Yamashita M, Casas‐Cordero R, Otero‐Corchón V, de Souza FS, Rubinstein M, Low MJ ( 2012 ) Obesity‐programmed mice are rescued by early genetic intervention. J Clin Invest 122: 4203 – 4212.
dc.identifier.citedreferenceColombo G, Lobina C, Carai MAM, Gessa GL ( 2006 ) Phenotypic characterization of genetically selected Sardinian alcohol‐preferring (sP) and ‐non‐preferring (sNP) rats. Addict Biol 11: 324 – 338.
dc.identifier.citedreferenceEdwards S, Guerrero M, Ghoneim OM, Roberts E, Koob GF ( 2012 ) Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol‐dependent rats. Addict Biol 17: 76 – 85.
dc.identifier.citedreferenceEisenhofer G, Lambie DG, Whiteside EA, Johnson RH ( 1985 ) Vasopressin concentrations during alcohol withdrawal. Br J Addict 80: 195 – 199.
dc.identifier.citedreferenceFroehlich JC, Hausauer BJ, Rasmussen DD ( 2013 ) Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone. Alcohol Clin Exp Res 37: 1763 – 1770.
dc.identifier.citedreferenceGoutier W, Kloeze M, McCreary AC ( 2016 ) Nicotine‐induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids. Addict Biol 21: 234 – 241.
dc.identifier.citedreferenceGriebel G, Simiand J, Serradeil‐Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P ( 2002 ) Anxiolytic‐ and antidepressant‐like effects of the non‐peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress‐related disorders. Proc Natl Acad Sci USA 99: 6370 – 6375.
dc.identifier.citedreferenceGulya K, Dave JR, Hoffman PL ( 1991 ) Chronic ethanol ingestion decreases vasopressin mRNA in hypothalamic and extrahypothalamic nuclei of mouse brain. Brain Res 557: 129 – 135.
dc.identifier.citedreferenceHarding AJ, Halliday GM, Ng JL, Harper CG, Kril JJ ( 1996 ) Loss of vasopressin‐immunoreactive neurons in alcoholics is dose‐related and time‐dependent. Neuroscience 72: 699 – 708.
dc.identifier.citedreferenceHernando F, Schoots O, Lolait SJ, Burbach JP ( 2001 ) Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 142: 1659 – 1668.
dc.identifier.citedreferenceHeyser CJ, Moc K, Koob GF ( 2003 ) Effects of naltrexone alone and in combination with acamprosate on alcohol deprivation effect in rats. Neuropsychopharmacology 28: 1463 – 1471.
dc.identifier.citedreferenceHwa LS, Chu A, Levinson SA, Kayyali TM, DeBold JF, Miczek KA ( 2011 ) Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% alcohol. Alcohol Clin Exp Res 35: 1938 – 1947.
dc.identifier.citedreferenceIshizawa H, Dave JR, Liu L, Tabakoff B, Hoffman PL ( 1990 ) Hypothalamic vasopressin mRNA levels in mice decreased after chronic ethanol ingestion. Eur J Pharmacol 189: 119 – 127.
dc.identifier.citedreferenceKatz DA, Locke C, Liu W, Zhang J, Achari R, Wesnes KA, Tracy KA ( 2016 ) Single‐dose interaction study of the arginine vasopressin type 1B receptor antagonist ABT‐436 and alcohol in moderate alcohol drinkers. Alcohol Clin Exp Res 40: 838 – 845.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acer13544.pdf
Size:
297.3KB
Format:
PDF
View/Open
Name:
acer13544_am.pdf
Size:
358.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.